HaoXinQing Completes Hundreds of Millions USD Series D Funding Round, Accelerates Digital Transformation in Mental Healthcare

Recently, VCBeat exclusively learned thatChina’s largest digital services group focused on mental health healthcare, Fine Hin Health Industry Group (hereinafter referred to as “Fine Hin”), has successfully completed a Series D financing round amounting to hundreds of millions of yuan. The investment was jointly made by Xuzhou Industrial Investment, Citic Medical, Zhongtai Fund, United Future, and other investors.

This also marks the first mega-round of financing in the digital health and mental health sectors since the Lunar New Year.

Since 2016, including the current round of financing, Haoxinqing has attracted substantial investment from numerous renowned institutions and industrial capital across six funding rounds. Notable investors include Enhua Pharmaceutical, Tonghe Yucheng, ByteDance, Fosun Health, and Decheng Capital, among other prominent firms.

Amid the ongoing slump in the primary market, Haoxinqing’s new round of financing amounting to hundreds of millions of yuan signals investors’ optimism about the prospects of the mental health industry, particularly their favor toward digital mental health technologies. This funding also provides strong momentum for Haoxinqing’s in-depth development in digital mental health services and its strategic layout in the broader mental health industry.

Since its inception, Beijing Fine Hin Mobile Medical Technology Co., Ltd. has consistently targeted the rapidly growing mental health and psychological wellness industry, building a comprehensive online and offline professional digital diagnosis and treatment system that covers both consumer (C-end) and business (B-end) sectors.Fine Hin has currently completed its strategic layout across four major business segments: the online psychological hospital, nationwide chain of psychological clinics, digital technology, and corporate mental health.

While continuously enriching the service offerings of its online consultation platform and integrating online with offline services, Fine Hin is also actively exploring further possibilities in digital AI technologies for mental health.

It was revealed that a portion of the funds raised in this round will also be prioritized for R&D and innovation in AI-powered psychological companionship robots and AI diagnostic technologies.This move is consistent with Fine Hin’s longstanding commitment to investing in mental health technology. By increasing R&D investment, Fine Hin aims to further enhance the intelligence of its AI-powered psychological companion robots, enabling them to more accurately understand users’ mental states and deliver more attentive, personalized companionship services. Meanwhile, the company seeks to achieve breakthroughs in diagnostic technologies to improve the accuracy and efficiency of mental disorder diagnoses, thereby providing a stronger technological foundation for mental health services.

Fine Hin has consistently leveraged data algorithms to achieve precise matching between users with mental health needs and physicians, while optimizing clinical pathways to further enhance diagnostic and treatment efficiency. Through years of sustained investment and accumulation, Fine Hin has independently developed an intelligent, big data-driven diagnosis and treatment system. This system features specialized functionalities tailored to various types of mental and psychological disorders, enabling its AI bots to rapidly assess the risk levels and categories of mental health conditions. By integrating modular and standardized components—including clinical psychological scale assessments, follow-up systems, electronic medical records, a pharmaceutical knowledge base, and clinical diagnosis systems—the Fine Hin platform can match users with appropriate specialists once results are obtained. Users can then autonomously select services to receive authoritative and comprehensive rehabilitation solutions.

These factors further solidify the leading position of Beijing Fine Hin Mobile Medical Technology Co., Ltd. in digital mental health technology services, particularly within the central nervous system and psychiatric sectors.